- Pirinixil
-
- $2500.00
-
2026-05-11
- CAS:65089-17-0
- Purity:
- Supply Ability: 10g
- Pirinixil
-
- $2500.00
-
2025-08-22
- CAS:65089-17-0
- Purity:
- Supply Ability: 10g
|
| | Pirinixil Basic information |
| Product Name: | Pirinixil | | Synonyms: | 2-[[4-Chloro-6-(2,3-dimethylphenylamino)-2-pyrimidinyl]thio]-N-(2-hydroxyethyl)acetamide;2-[[4-Chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl]thio]-N-(2-hydroxyethyl)acetamide;Pirinixil;Acetamide, 2-[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-N-(2-hydroxyethyl)- | | CAS: | 65089-17-0 | | MF: | C16H18ClN3OS | | MW: | 366.87 | | EINECS: | | | Product Categories: | | | Mol File: | 65089-17-0.mol |  |
| | Pirinixil Chemical Properties |
| Melting point | 145°C | | Boiling point | 609.6±55.0 °C(Predicted) | | density | 1.2894 (rough estimate) | | refractive index | 1.6100 (estimate) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 13.27±0.46(Predicted) |
| | Pirinixil Usage And Synthesis |
| Uses | Pirinixil, is an absorbable hypolipidemic agent of low toxicity. | | Safety Profile | Suspected carcinogen
with experimental carcinogenic data.
Mutation data reported. When heated to
decomposition it emits very toxic fumes of
Cl-, NOx and SOx | | in vivo | Pirinixil is a hypolipidemic agent of low toxicity. Total cholesterol is reduced by Pirinixi in the spleen, kidney and heart of rats. Pirinixil decreases the estimated total body cholesterol approximately 40%[1]. Pirinixil increases plasma cholesterol levels significantly without affecting plasma triglycerides. Liver cholesterol and triglycerides are markedly reduced by Pirinixil, while combined plasma and liver lipid levels decrease approximately 20%. Liver HMG-CoA reductase activity is not affected, but cholesterol 7α-hydroxylase is significantly reduced by Pirinixil[2]. |
| | Pirinixil Preparation Products And Raw materials |
|